Featured Story TAVR at Johns Hopkins
Originally intended for high-risk patients, TAVR is now being offered to low-risk ones as part of a national clinical trial that includes Johns Hopkins.
Cardiovascular Report Winter 2019
News for Physicians from Johns Hopkins Medicine
Articles in this Issue
-
Database Helps Track Rare Congenital Aortic Syndromes
Patients dealing with rare anomalies of the peripheral vascular system can now turn to a database linking patients to physicians to help relieve complications.
-
Reducing Inflammation After Heart Attacks May Prevent Secondary Events
A treatment normally reserved for patients with stubbornly high low-density lipoprotein (LDL) cholesterol offers promise to reduce inflammation after heart attacks.
-
New Faculty Members
Meet five new experts with specialized cardiovascular skills and diverse research interests.
-
ECMO Team Approach Improves Odds for Critically Ill Patients
Specialists work together to review concerns as the machine allows critically ill patients their best chance to recover function.
